nanoSkunkWorkX converts bulk graphene into manufacturable systems through rigorous material science and engineering discipline. The company focuses its deep technology platform across three primary frontiers: advanced chips, hydrogen applications, and specialized diagnostics. They deliver reliable, data-driven outcomes rather than conceptual performance claims.
Funding
Funding not disclosed
Founders
Product
Problem
Conventional diagnostic methods for communicable and non-communicable diseases often involve time-consuming procedures, reliance on specialized laboratory equipment, and high costs, particularly impacting accessibility in low-resource settings. The need for rapid, accurate, and affordable diagnostic solutions remains unmet, hindering timely intervention and effective disease management.
Solution
nanoSkunkWorkX is developing a portable, low-cost biosensing and diagnostics platform, SKUNKBOX Dx, that delivers rapid, point-of-care results with accuracy comparable to RT-PCR. The platform utilizes a proprietary nano-engineered Sensor Dot (nSD) technology, embedding 3D-graphene structures for electrochemical sensing. This approach eliminates the need for molecular labs, reduces reliance on imported reagents, and lowers energy consumption. The SKUNKBOX Dx platform is designed to be easily modified for detecting a wide range of emerging diseases, offering a future-proofed solution for diagnostic needs.
Target Audience
The primary target audience includes healthcare providers, particularly in low and middle-income countries, seeking affordable, rapid, and accurate diagnostic solutions, as well as organizations involved in disaster response and remote healthcare delivery.
Features
- Portable biosensing and diagnostics platform for point-of-care testing
- Proprietary nano-engineered Sensor Dot (nSD) technology with 3D-graphene structures
- Electrochemical sensing for rapid and accurate detection
- RT-PCR quality results at a fraction of the cost and time
- No requirement for molecular laboratory infrastructure
- Easily modifiable and configurable for tackling emerging diagnostic needs
- Potential for saliva-based glucose sensing for non-invasive diabetes monitoring